SecurityGSK / GlaxoSmithKline plc
InstitutionJarislowsky, Fraser Ltd
Shares278,443
Value $ 11,224,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Jarislowsky, Fraser Ltd reports 8.30% decrease in ownership of GSK / GlaxoSmithKline plc

August 10, 2018 - Jarislowsky, Fraser Ltd has filed a 13F-HR form disclosing ownership of 278,443 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $11,224,000 USD as of June 30, 2018. Jarislowsky, Fraser Ltd had filed a previous 13F-HR on May 14, 2018 disclosing 303,633 shares of GlaxoSmithKline plc at a value of $11,862,000 USD. This represents a change in shares of -8.30 percent and a change in value of -5.38 percent during the quarter.

Other investors with positions similar to Jarislowsky, Fraser Ltd include JP Morgan Chase & Co, United Capital Financial Advisers, Llc, Lincluden Management Ltd, Raymond James Financial Services Advisors, Inc., Freestone Capital Holdings, LLC, and Eversept Partners, Llc.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 39.69 278,443 -8.30 11,224 -5.38 -1,000 362 3.05
2018-03-31 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 37.27 303,633 -20.73 11,862 -12.69 -2,959 1,235 9.09
2017-12-31 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 38.03 383,030 -53.53 13,586 -59.40 -16,780 -3,096 -9.25
2017-09-30 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 41.86 824,206 -2.30 33,462 -8.01 -811 -2,102 -5.78
2017-06-30 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 42.64 843,578 -3.71 36,375 -1.52 -1,387 825 2.23
2017-03-31 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 40.34 876,115 -5.14 36,937 3.85 -1,917 3,285 9.23
2016-12-31 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 40.82 923,631 10.79 35,569 -1.08 3,671 -4,059 -11.29
2016-09-30 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 43.23 833,699 2.83 35,957 2.33 993 -173 -0.49
2016-06-30 13F-HR GlaxoSmithKline plc ADR ADR 37733W105 41.94 810,733 4.88 35,137 12.09 1,582 2,209 7.05
2016-03-31 13F-HR GLAXOSMITHKLINE PLC-SPON ADR ADR 37733W105 40.45 773,021 4.92 31,346 5.45 1,467 152 0.51
2015-12-31 13F-HR GLAXOSMITHKL-ADR ADR 37733W105 39.40 736,748 0.47 29,727 5.44 137 1,396 4.95
2015-09-30 13F-HR GLAXOSMITHKL-ADR ADR 37733W105 40.05 733,283 13.36 28,194 4.65 3,461 -2,208 -8.20
2015-06-30 13F-HR/A-1 GLAXOSMITHKL-ADR ADR 37733W105 43.90 646,864 42.57 26,941 28.66 8,479 -2,477 -11.83
2015-06-30 13F-HR GLAXOSMITHKL-ADR ADR 37733W105 646,864 26,941
2015-03-31 13F-HR GLAXOSMITHKLINE PLC ADR ADR 37733W105 44.44 453,719 17.58 20,939 26.96 3,015 1,432 8.68
2014-12-31 13F-HR GLAXOSMITHKL-ADR ADR 37733W105 44.35 385,873 7.78 16,492 0.21 1,236 -1,201 -7.30
2014-09-30 13F-HR GLAXOSMITHKL-ADR ADR 37733W105 49.72 358,009 -5.05 16,457 -18.39 -947 -2,761 -13.69
2014-06-30 13F-HR GLAXOSMITHKL-ADR SPONSORED ADR 37733W105 377,053 20,165


CUSIP: 37733W105